Harry Yang

About the Author

Harry Yang is a distinguished biostatistician and pharmaceutical executive with over two decades of experience in clinical research and drug development. Holding advanced degrees in statistics and public health, he has held leadership roles at major biotech firms, where he spearheaded innovations in trial design and data analytics to accelerate therapeutic breakthroughs. Yang's expertise bridges cutting-edge technology with regulatory compliance, making complex scientific processes accessible to industry professionals. His seminal work, Clinical Trial Modernization: Technological, Operational, and Regulatory Advances (Chapman & Hall/CRC Biostatistics Series), has become a cornerstone reference for optimizing clinical trials in an era of rapid innovation. Through his writing, Yang empowers researchers to navigate the evolving landscape of biopharmaceutical R&D with precision and foresight.